These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3092589

  • 1. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B, Gallego J, Boronat F, Moreno B, Mompó JA, Jiménez JF.
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract] [Full Text] [Related]

  • 2. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B, Sánchez A, Boronat F, Gallego J, Moreno B, Alonso M, Martínez R, Vera CD, Jiménez JF.
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma].
    Iborra Juan I, Monrós Lliso JL, Ricós Torrent JV, Mazcuñan Fuentes F, Casanova Ramón-Borja J, Solsona Narbón E.
    Actas Urol Esp; 1988 Apr; 12(1):20-4. PubMed ID: 3389211
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL, Ojea A, Jamardo D, Figueiredo L.
    Actas Urol Esp; 1984 Apr; 8(4):325-8. PubMed ID: 6435407
    [No Abstract] [Full Text] [Related]

  • 5. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA, de la Peña J, Hidalgo L, Cisneros J, Jiménez León J, Machuca J, Perdices C.
    Arch Esp Urol; 1985 Apr; 38(6):545-53. PubMed ID: 3938633
    [No Abstract] [Full Text] [Related]

  • 6. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1989 Apr; 13(1):41-3. PubMed ID: 2496584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Apr; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 9. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.
    Jauhiainen K, Alfthan O.
    Ann Chir Gynaecol; 1984 Apr; 73(4):206-10. PubMed ID: 6508201
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative study of adriamycin and thiotepa in the chemoprophylaxis of superficial bladder tumors].
    Salinas Sánchez AS, Moreno Avilés J, Pérez Albacete M, Salmerón Lopez-Rua J, Guardiola Más A, Server Falgas G.
    Actas Urol Esp; 1989 Apr; 13(2):99-102. PubMed ID: 2499166
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N, Arima K, Sugimura Y.
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [Abstract] [Full Text] [Related]

  • 15. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A, Gutiérrez Sanz-Gadea C, Hernández Fernández C, Mateos Torres A, Maganto Pavón E, Mayayo Dehesa T.
    Actas Urol Esp; 1985 Aug; 9(2):135-46. PubMed ID: 3925729
    [No Abstract] [Full Text] [Related]

  • 16. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J, Bouffier B, Etievent JP, Bittard M.
    J Urol (Paris); 1983 Aug; 89(2):85-9. PubMed ID: 6408192
    [Abstract] [Full Text] [Related]

  • 17. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984 Aug; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 18. Chemotherapeutic prophylaxis of superficial bladder tumors.
    Huncharek M, Kupelnick B.
    Oncology (Williston Park); 2001 Sep; 15(9):1106. PubMed ID: 11589061
    [No Abstract] [Full Text] [Related]

  • 19. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor.
    Llopis B, Gallego J, Mompó JA, Boronat F, Alonso M, Moreno B, Jiménez JF.
    Eur Urol; 1986 Sep; 12(4):253-6. PubMed ID: 3091370
    [Abstract] [Full Text] [Related]

  • 20. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors.
    Llopis B, Gallego J, Mompó JA, Boronat F, Jiménez JF.
    Eur Urol; 1985 Sep; 11(2):73-8. PubMed ID: 3924624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.